NEW YORK -- A federal court has ordered Johnson & Johnson/Merck, maker of Pepcid AC, and SmithKline Beecham, maker of Tagamet HB, to modify promotional materials for their respective H2 antagonist products. e during a multimillion-dollar marketing battle that has been in progress since both companies launched over-the-counter stomach remedy products that are low-dose versions of their anti-ulcer prescription counterparts. The ruling upholds SmithKline Beecham's position that Pepcid AC ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.